chlorpromazine has been researched along with Dyskinesia, Medication-Induced in 96 studies
Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This pooled analysis of four 6-week, randomized, open-label, parallel trials of patients with schizophrenia (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) compared the efficacy and tolerability of olanzapine (5-20 mg/d) with those of chlorpromazine (200-800 mg/d)." | 9.12 | Olanzapine versus chlorpromazine in the treatment of schizophrenia: a pooled analysis of four 6-week, randomized, open-label studies in the Middle East and North Africa. ( Dominguez, S; Dossenbach, M; Huang, X; Kryzhanovskaya, L; Saylan, M; Treuer, T, 2007) |
| "Patients with acute exacerbation of schizophrenia (DSM-III-R criteria; n = 158) were allocated on a random, double-blind basis to receive zotepine (150 or 300 mg/day), chlorpromazine (300 or 600 mg/day) or placebo for 8 weeks." | 9.09 | A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. ( Butler, A; Cooper, SJ; Raniwalla, J; Tweed, J; Welch, C, 2000) |
| "We have observed two cases of chlorpromazine-induced neuroleptic malignant syndrome (NMS); both were transiently responsive to intravenous diazepam challenge, but not to blind placebo or amyobarbitol." | 9.05 | Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam. ( Lew, TY; Tollefson, G, 1983) |
| "A four week double-blind study comparing pimozide and chlorpromazine was designed to test the hypothesis that pimozide, a powerful dopamine receptor blocker, is more effective in the treatment of acute schizophrenia than chlorpromazine." | 9.05 | Comparison of pimozide and chlorpromazine in acute schizophrenia. ( Allan, T; McClure, DJ; Pecknold, JC; Wrzesinski, L, 1982) |
| "To determine the clinical effects, safety and cost-effectiveness of chlorpromazine compared with clotiapine for adults with schizophrenia." | 8.95 | Chlorpromazine versus clotiapine for schizophrenia. ( Bazrafshan, A; Esmailian, S; Goughari, AS; Mazhari, S; Shah-Esmaeili, A; Zare, M, 2017) |
| "This pooled analysis of four 6-week, randomized, open-label, parallel trials of patients with schizophrenia (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) compared the efficacy and tolerability of olanzapine (5-20 mg/d) with those of chlorpromazine (200-800 mg/d)." | 5.12 | Olanzapine versus chlorpromazine in the treatment of schizophrenia: a pooled analysis of four 6-week, randomized, open-label studies in the Middle East and North Africa. ( Dominguez, S; Dossenbach, M; Huang, X; Kryzhanovskaya, L; Saylan, M; Treuer, T, 2007) |
| "Patients with acute exacerbation of schizophrenia (DSM-III-R criteria; n = 158) were allocated on a random, double-blind basis to receive zotepine (150 or 300 mg/day), chlorpromazine (300 or 600 mg/day) or placebo for 8 weeks." | 5.09 | A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. ( Butler, A; Cooper, SJ; Raniwalla, J; Tweed, J; Welch, C, 2000) |
| "We have observed two cases of chlorpromazine-induced neuroleptic malignant syndrome (NMS); both were transiently responsive to intravenous diazepam challenge, but not to blind placebo or amyobarbitol." | 5.05 | Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam. ( Lew, TY; Tollefson, G, 1983) |
| "A four week double-blind study comparing pimozide and chlorpromazine was designed to test the hypothesis that pimozide, a powerful dopamine receptor blocker, is more effective in the treatment of acute schizophrenia than chlorpromazine." | 5.05 | Comparison of pimozide and chlorpromazine in acute schizophrenia. ( Allan, T; McClure, DJ; Pecknold, JC; Wrzesinski, L, 1982) |
| "To determine the clinical effects, safety and cost-effectiveness of chlorpromazine compared with clotiapine for adults with schizophrenia." | 4.95 | Chlorpromazine versus clotiapine for schizophrenia. ( Bazrafshan, A; Esmailian, S; Goughari, AS; Mazhari, S; Shah-Esmaeili, A; Zare, M, 2017) |
| " We have pursued evidence for the existence and nature of discontinuation syndromes following neuroleptics through reports of difficulties following the use of dopamine blocking anti-emetics, the use of chlorpromazine to treat tuberculosis, the use of antidepressant-neuroleptic combinations in affective disorders, the occurrence of tardive syndromes and studies designed to establish the existence of discontinuation syndromes in schizophrenia." | 4.80 | Neuroleptic discontinuation syndromes. ( Healy, D; Tranter, R, 1998) |
| "Three patients, aged 23-33 years, with the diagnosis of schizophrenia, developed symptoms of tardive dyskinesia while receiving neuroleptic treatment, mostly with haloperidol." | 3.65 | Diazepam in the treatment of tardive dyskinesia. Preliminary observations. ( Singh, MM, 1976) |
| "Chlorpromazine was found to be significantly better than remoxipride on the dropout rate due to inefficacy, Clinical Global Impression (CGI) of severity of illness and Brief Psychiatric Rating Scale (BPRS)." | 2.67 | A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation. ( Chouinard, G, 1990) |
| "Pimozide was found to exert somewhat less of an overall therapeutic effect than chlorpromazine, particularly in highly agitated patients." | 2.65 | Pimozide in the treatment of newly admitted schizophrenic patients. ( Annable, L; Chouinard, G, 1982) |
| " This study was planned to investigate changes in striatal levels of norepinephrine, dopamine and serotonin after acute and chronic administration of classical neuroleptics (haloperidol and chlorpromazine)." | 1.35 | In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration. ( Bishnoi, M; Chopra, K; Kulkarni, SK, 2009) |
| " The present study compares the effect of chronic administration of typical and atypical antipsychotics on neurochemical profile in rat forebrain." | 1.34 | Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia. ( Bishnoi, M; Chopra, K; Kulkarni, SK; Kumar, A, 2007) |
| " Chronic administration of haloperidol (1 mg/kg) and chlorpromazine (5 mg/kg) resulted in a time-dependent increase in orofacial hyperkinetic movements." | 1.34 | Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia. ( Bishnoi, M; Chopra, K; Kulkarni, SK, 2007) |
| "Risperidone (4 mg/day) was added to her drug regimen and after increasing the dosage to 6 mg/day, she began to exhibit retrocollis." | 1.31 | Tardive dystonia provoked by concomitantly administered risperidone. ( Hori, M; Hori, T; Kawanishi, Y; Shiraishi, H; Suzuki, T; Tachikawa, H, 2000) |
| "Levodopa-induced dyskinesias (LID) in Parkinson's disease (PD) may be classified into three main categories: "On" dyskinesias, diphasic dyskinesias (DD), and "off" periods." | 1.28 | Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification. ( Gershanik, O; Luquin, MR; Obeso, JA; Scipioni, O; Vaamonde, J, 1992) |
| "Of these patients, 85% experienced withdrawal symptoms, mainly insomnia, anxiety, and tensional restlessness." | 1.27 | Withdrawal symptoms after long-term treatment with low-potency neuroleptics. ( Annable, L; Bradwejn, J; Chouinard, G; Jones, BD; Ross-Chouinard, A, 1984) |
| " Such variations have been attributed to individual metabolism, pharmacologic differences, and age--all of which may need careful consideration in prescribing an appropriate dosage regimen for a given patient." | 1.27 | Interpatient variations in antipsychotic therapy. ( Gershon, S; McIntyre, IM, 1985) |
| "Relationships of neuroleptic dosage and tardive dyskinesia with measures of attentional, information-processing, and psychophysiological dysfunctions in medicated chronic schizophrenics were explored by correlational and stepwise multiple-regression analysis." | 1.27 | Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics. ( Coyne, L; Hayes, K; Lacoursiere, R; Mazur, D; Spohn, HE, 1985) |
| "Rats with ablated frontal sensorimotor cortex and one with ablated sensorimotor connections to forebrain showed more vacuous chewing movements following 6-week chronic administration of a neuroleptic than did occipitally damaged rats or normal controls who were treated in the same way." | 1.26 | Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia. ( Glassman, HN; Glassman, RB, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 60 (62.50) | 18.7374 |
| 1990's | 17 (17.71) | 18.2507 |
| 2000's | 15 (15.63) | 29.6817 |
| 2010's | 4 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mazhari, S | 1 |
| Esmailian, S | 1 |
| Shah-Esmaeili, A | 1 |
| Goughari, AS | 1 |
| Bazrafshan, A | 1 |
| Zare, M | 1 |
| Deng, H | 1 |
| Xu, J | 1 |
| Kulkarni, SK | 5 |
| Bishnoi, M | 5 |
| Chopra, K | 5 |
| Lee, J | 1 |
| Jiang, J | 1 |
| Sim, K | 1 |
| Chong, SA | 1 |
| Kane, JM | 1 |
| Correll, CU | 1 |
| Dean, CE | 1 |
| Kuskowski, MA | 1 |
| Caligiuri, MP | 2 |
| Kumar, A | 1 |
| Dossenbach, M | 1 |
| Treuer, T | 1 |
| Kryzhanovskaya, L | 1 |
| Saylan, M | 1 |
| Dominguez, S | 1 |
| Huang, X | 1 |
| Preskorn, SH | 1 |
| Lerner, V | 1 |
| Miodownik, C | 1 |
| Kaptsan, A | 1 |
| Bersudsky, Y | 1 |
| Libov, I | 1 |
| Sela, BA | 1 |
| Witztum, E | 1 |
| Weiden, PJ | 1 |
| DeVeaugh-Geiss, J | 1 |
| Glassman, RB | 1 |
| Glassman, HN | 1 |
| Ringwald, E | 1 |
| Lustig, A | 1 |
| Moscovici, M | 1 |
| Spiegel, R | 1 |
| Vamos, E | 1 |
| Gale, K | 1 |
| Casu, M | 1 |
| Klawans, HL | 2 |
| Goetz, CG | 2 |
| Carvey, P | 2 |
| Brown, WA | 1 |
| Hollister, LE | 1 |
| Chouinard, G | 3 |
| Bradwejn, J | 1 |
| Annable, L | 2 |
| Jones, BD | 1 |
| Ross-Chouinard, A | 1 |
| Tuason, VB | 1 |
| Escobar, JI | 1 |
| Garvey, M | 1 |
| Schiele, B | 1 |
| Lew, TY | 1 |
| Tollefson, G | 1 |
| McKinney, WT | 1 |
| Moran, EC | 1 |
| Kraemer, GW | 1 |
| Prange, AJ | 1 |
| Yassa, R | 2 |
| Dimitry, R | 1 |
| Mueller, J | 1 |
| Aminoff, MJ | 1 |
| Pecknold, JC | 1 |
| McClure, DJ | 1 |
| Allan, T | 1 |
| Wrzesinski, L | 1 |
| Weiner, WJ | 1 |
| Werner, TR | 1 |
| Smith, JM | 1 |
| Burke, MP | 1 |
| Moon, CO | 1 |
| Breuning, SE | 3 |
| Ferguson, DG | 3 |
| Cullari, S | 2 |
| O'Neill, MJ | 1 |
| Risch, SC | 1 |
| Cohen, RM | 1 |
| Kalin, NH | 1 |
| Van Putten, T | 1 |
| May, PR | 1 |
| Wilkins, JN | 1 |
| Awad, AG | 1 |
| Gingell, K | 1 |
| Nadarajah, J | 1 |
| Lewander, T | 1 |
| Bollini, P | 1 |
| Pampallona, S | 1 |
| Orza, MJ | 1 |
| Adams, ME | 1 |
| Chalmers, TC | 1 |
| Tranter, R | 1 |
| Healy, D | 1 |
| Cohen, D | 1 |
| Cooper, SJ | 2 |
| Tweed, J | 1 |
| Raniwalla, J | 1 |
| Butler, A | 1 |
| Welch, C | 1 |
| Khan, M | 1 |
| Farver, D | 1 |
| Tachikawa, H | 1 |
| Suzuki, T | 1 |
| Kawanishi, Y | 1 |
| Hori, M | 1 |
| Hori, T | 1 |
| Shiraishi, H | 1 |
| Liao, DL | 1 |
| Yeh, YC | 1 |
| Chen, HM | 1 |
| Chen, H | 1 |
| Hong, CJ | 1 |
| Tsai, SJ | 1 |
| Darvesh, S | 1 |
| MacKnight, C | 1 |
| Rockwood, K | 1 |
| Quitkin, F | 2 |
| Rifkin, A | 2 |
| Gochfeld, L | 1 |
| Klein, DF | 2 |
| Lee, AS | 1 |
| Davis, JM | 1 |
| Casper, R | 1 |
| Hogarty, GE | 1 |
| Ulrich, RF | 1 |
| Kane, J | 1 |
| Struve, F | 1 |
| Rotenberg, VS | 1 |
| Arshavsky, VV | 1 |
| Guy, W | 1 |
| Petrie, W | 1 |
| Cleary, P | 1 |
| Gelenberg, AJ | 1 |
| Doller, JC | 1 |
| Bourgeois, M | 1 |
| Doongaji, DR | 1 |
| Shader, RI | 1 |
| Elkins, R | 1 |
| Ciraulo, D | 1 |
| Salzman, C | 1 |
| Levinson, P | 1 |
| Malen, R | 1 |
| Hogben, G | 1 |
| Smith, H | 1 |
| Eibergen, RD | 2 |
| Carlson, KR | 2 |
| Pfefferbaum, A | 1 |
| Berger, PA | 1 |
| Allen, RE | 1 |
| Stimmel, GL | 1 |
| Sedvall, G | 1 |
| Jeste, DV | 2 |
| Olgiati, SG | 1 |
| Ghali, AY | 1 |
| Singh, MM | 1 |
| Sandyk, R | 1 |
| Kay, SR | 2 |
| Koshino, Y | 1 |
| Madokoro, S | 1 |
| Ito, T | 1 |
| Horie, T | 1 |
| Mukai, M | 1 |
| Isaki, K | 1 |
| Luquin, MR | 1 |
| Scipioni, O | 1 |
| Vaamonde, J | 1 |
| Gershanik, O | 1 |
| Obeso, JA | 1 |
| Sachdev, P | 1 |
| Tang, WM | 1 |
| Gregory, RP | 1 |
| Smith, PT | 1 |
| Rudge, P | 1 |
| Saltz, BL | 1 |
| McClelland, HA | 1 |
| Metcalfe, AV | 1 |
| Kerr, TA | 1 |
| Dutta, D | 1 |
| Watson, P | 1 |
| Mackert, A | 1 |
| Woyth, C | 1 |
| Flechtner, KM | 1 |
| Frick, K | 1 |
| Sethi, KD | 1 |
| Hitri, A | 1 |
| Diamond, BI | 1 |
| Merriam, AE | 1 |
| Opler, LA | 1 |
| Kushner, SF | 1 |
| van Praag, HM | 1 |
| Rao, JM | 1 |
| Cowie, VA | 1 |
| Mathew, B | 1 |
| Deniker, P | 1 |
| Harris, MJ | 1 |
| Doherty, MM | 1 |
| King, DJ | 1 |
| Tanner, CM | 1 |
| McIntyre, IM | 1 |
| Gershon, S | 1 |
| Johnson, DA | 1 |
| Spohn, HE | 1 |
| Coyne, L | 1 |
| Lacoursiere, R | 1 |
| Mazur, D | 1 |
| Hayes, K | 1 |
| Trelles, L | 1 |
| Trelles, JO | 1 |
| Castaneda, C | 1 |
| Castro, C | 1 |
| Kovacic, B | 1 |
| Ruffing, D | 1 |
| Stanley, M | 1 |
| Dufresne, RL | 1 |
| Wagner, RL | 1 |
| Galdi, J | 1 |
| Bonato, RR | 1 |
| Bowers, MB | 1 |
| Swigar, ME | 1 |
| Canoso, RT | 1 |
| Romero, JA | 1 |
| Yunis, EJ | 1 |
| Chaturvedi, SK | 1 |
| Gerhardt, S | 1 |
| Gerber, R | 1 |
| Liebman, JM | 1 |
| Markianos, M | 1 |
| Tripodianakis, J | 1 |
| Addonizio, G | 1 |
12 reviews available for chlorpromazine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Chlorpromazine versus clotiapine for schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Dibenzothiazepines; Dyskinesia, Drug-Induced; Humans; Intentio | 2017 |
Wendan decoction (Traditional Chinese medicine) for schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Drug Therapy, Combination; Drugs, Chinese Herbal; Dyskinesia, | 2017 |
Past and present progress in the pharmacologic treatment of schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Controlled Clinical Trials as Topic; Diabetes Melli | 2010 |
Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.
Topics: 4-Aminobutyrate Transaminase; Afferent Pathways; Aminocaproates; Animals; Basal Ganglia; Behavior, A | 1981 |
Prolactin levels and effects of neuroleptics.
Topics: Antipsychotic Agents; Biological Availability; Chlorpromazine; Drug Tolerance; Dyskinesia, Drug-Indu | 1983 |
Drug treatment of schizophrenia.
Topics: Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Chemical Phenomena; Ch | 1984 |
Neuroleptics and the neuroleptic-induced deficit syndrome.
Topics: Affective Symptoms; Antipsychotic Agents; Arousal; Chlorpromazine; Dyskinesia, Drug-Induced; Humans; | 1994 |
Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials.
Topics: Antipsychotic Agents; Chlorpromazine; Chronic Disease; Dose-Response Relationship, Drug; Dyskinesia, | 1994 |
Neuroleptic discontinuation syndromes.
Topics: Antiemetics; Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Humans; Mood Disorders; | 1998 |
Rapid resolution of antipsychotic-induced tardive dyskinesia with olanzapine.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Chlorpromazine; Chronic Disease; Dysk | 2000 |
Antipsychotic drugs: clinical pharmacology and therapeutic use.
Topics: Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Do | 1977 |
Antipsychotic medication: clinical guidelines for maintenance therapy.
Topics: Administration, Oral; Ambulatory Care; Anti-Anxiety Agents; Antipsychotic Agents; Basal Ganglia Dise | 1985 |
16 trials available for chlorpromazine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Olanzapine versus chlorpromazine in the treatment of schizophrenia: a pooled analysis of four 6-week, randomized, open-label studies in the Middle East and North Africa.
Topics: Adolescent; Adult; Africa, Northern; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Dyskines | 2007 |
Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Cross-Over Studies; Doubl | 2007 |
Loxapine versus chlorpromazine in paranoid schizophrenia: a double-blind study.
Topics: Adult; Basal Ganglia Diseases; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; Dizziness | 1984 |
Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam.
Topics: Brain; Chlorpromazine; Diazepam; Dopamine; Dyskinesia, Drug-Induced; Dystonia; Female; Fever; gamma- | 1983 |
Pimozide in the treatment of newly admitted schizophrenic patients.
Topics: Acute Disease; Adult; Chlorpromazine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; | 1982 |
Comparison of pimozide and chlorpromazine in acute schizophrenia.
Topics: Acute Disease; Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Dru | 1982 |
A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Dibenzothiepins; Dose-Respon | 2000 |
Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; DNA; Dyskinesia, Drug-Induced; Female | 2001 |
Antipsychotic drugs: clinical pharmacology and therapeutic use.
Topics: Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Do | 1977 |
Temporal effects of drug and placebo in delaying relapse in schizophrenic outpatients.
Topics: Aftercare; Chlorpromazine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Humans; Longitudinal | 1977 |
Are prophylactic antiparkinson drugs necessary? A controlled study of procyclidine withdrawal.
Topics: Adult; Aftercare; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; D | 1978 |
The incidence of treatment emergent symptoms under chlorpromazine and placebo conditions [proceedings].
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Humans; Male; Pla | 1978 |
Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study.
Topics: Adult; Aged; Chlorpromazine; Clinical Trials as Topic; Clozapine; Dibenzazepines; Double-Blind Metho | 1979 |
A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Benzamides; Chlorpromazine; Clonazepam; Dose | 1990 |
Tardive dystonia. The benefits of time.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dys | 1989 |
Relationship of adverse drug reactions to length of hospital-stay in genetically subgrouped schizophrenics.
Topics: Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Me | 1988 |
69 other studies available for chlorpromazine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
Topics: Animals; Antipsychotic Agents; Basal Ganglia; Behavior, Animal; Catalepsy; Chlorpromazine; Corpus St | 2009 |
The prevalence of tardive dyskinesia in Chinese Singaporean patients with schizophrenia: revisited.
Topics: Adult; Aged; Antipsychotic Agents; Asian People; Chlorpromazine; Dyskinesia, Drug-Induced; Female; H | 2010 |
Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
Topics: Adult; Age Distribution; Age Factors; Aged; Aging; Antipsychotic Agents; Chlorpromazine; Craniocereb | 2006 |
Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Body Weight; Chlorpromazine; Clozapine; Dopamine; Dyskinesia, Drug-In | 2007 |
Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
Topics: Animals; Anti-Dyskinesia Agents; Antioxidants; Antipsychotic Agents; Catalase; Chlorpromazine; Diaze | 2007 |
Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Brain; Chlorpromazine; Dopamine; Dyskinesia, Drug-I | 2007 |
The evolution of antipsychotic drug therapy: reserpine, chlorpromazine, and haloperidol.
Topics: Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Europe; Haloperidol; History, 20th C | 2007 |
U-74500A (lazaroid), a 21-aminosteroid attenuates neuroleptic-induced orofacial dyskinesia.
Topics: Animals; Antioxidants; Antipsychotic Agents; Chlorpromazine; Disease Models, Animal; Dyskinesia, Dru | 2007 |
Antipsychotic-induced movement disorders - forgotten but not gone.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Brain; Chlorpromazine; Clozapine; Dopamine; Dyskinesi | 2008 |
Tardive Tourette syndrome.
Topics: Aged; Antipsychotic Agents; Chlorpromazine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Hum | 1980 |
Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Brain; Chlorpromazine; Di | 1980 |
[Effect of high single doses of bromocriptine in schizophrenic patients with elevated serum prolactin levels and extrapyramidal side effects associated with neuroleptic treatment (author's transl)].
Topics: Adult; Antipsychotic Agents; Bromocriptine; Chlorpromazine; Chronic Disease; Dose-Response Relations | 1980 |
Animal models of tardive dyskinesias.
Topics: Animals; Antipsychotic Agents; Apomorphine; Chlorpromazine; Disease Models, Animal; Dyskinesia, Drug | 1983 |
Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
Topics: Adult; Akathisia, Drug-Induced; Ambulatory Care; Antipsychotic Agents; Anxiety Disorders; Chlorproma | 1984 |
Long-term chlorpromazine in rhesus monkeys: production of dyskinesias and changes in social behavior.
Topics: Aggression; Animals; Chlorpromazine; Dyskinesia, Drug-Induced; Hand; Humans; Macaca mulatta; Mouth; | 1980 |
Single phenothiazines and tardive dyskinesia.
Topics: Aged; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Thioridazine; Trifluope | 1983 |
Tourette-like syndrome after long-term neuroleptic drug treatment.
Topics: Adult; Chlorpromazine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Substance Withdrawal Syn | 1982 |
Mania-induced remission of tardive dyskinesia in manic-depressive illness.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Remiss | 1982 |
Long-term changes in AIMS ratings and their relation to medication history [proceedings].
Topics: Age Factors; Aged; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Schi | 1981 |
Analysis of single, double-blind procedures, maintenance of placebo effects, and drug-induced dyskinesia with mentally retarded persons--a brief report [proceedings].
Topics: Adolescent; Adult; Aged; Chlorpromazine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Halo | 1981 |
Analysis of single-double blind procedures, maintenance of placebo effects and drug induced dyskinesia with mentally retarded persons.
Topics: Adult; Aged; Chlorpromazine; Double-Blind Method; Drug Evaluation; Dyskinesia, Drug-Induced; Female; | 1980 |
Comparison of psychotropic drug, response cost, and psychotropic drug plus response cost procedures for controlling institutionalized mentally retarded persons.
Topics: Adolescent; Adult; Aged; Behavior Therapy; Chlorpromazine; Double-Blind Method; Dyskinesia, Drug-Ind | 1980 |
Propranolol, chlorpromazine, and tardive dyskinesia.
Topics: Biological Availability; Chlorpromazine; Drug Interactions; Dyskinesia, Drug-Induced; Propranolol | 1980 |
Importance of akinesia: plasma chlorpromazine and prolactin levels.
Topics: Adult; Affective Symptoms; Chlorpromazine; Dyskinesia, Drug-Induced; Humans; Prolactin; Schizophreni | 1980 |
Subjective response to neuroleptics in schizophrenia.
Topics: Adult; Affective Symptoms; Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Female; H | 1993 |
A controlled community study of movement disorder in people with learning difficulties on anti-psychotic medication.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Diagnosis, Differential; Dose-Response Relationship, Dr | 1994 |
What is appropriate disclosure?
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Humans; In | 1999 |
Tardive dystonia provoked by concomitantly administered risperidone.
Topics: Adolescent; Antipsychotic Agents; Chlorpromazine; Drug Therapy, Combination; Dyskinesia, Drug-Induce | 2000 |
Butyrylcholinesterase and cognitive function.
Topics: Adult; Brain; Butyrylcholinesterase; Chlorpromazine; Cholinergic Antagonists; Cognition Disorders; D | 2001 |
Tardive dyskinesia: are first signs reversible?
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloper | 1977 |
Drug-induced dystonic reactions.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Hum | 1977 |
Search activity and its impact on experimental and clinical pathology.
Topics: Acoustic Stimulation; Alcoholism; Animals; Anxiety; Brain Mapping; Chlorpromazine; Dyskinesia, Drug- | 1979 |
[Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital].
Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Chlorpromazine; Diagnosis, Differential; Dyskine | 1977 |
The treatment of tardive dyskinesia with penfluridol. A case report.
Topics: Adult; Chlorpromazine; Dyskinesia, Drug-Induced; Humans; Male; Penfluridol; Piperidines; Trifluopera | 1977 |
On guidelines for maximum dosages.
Topics: Chlorpromazine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Middle Aged; Tra | 1978 |
Psychological factors in susceptibility to drug-induced extrapyramidal symptoms.
Topics: Adult; Basal Ganglia Diseases; Chlorpromazine; Dose-Response Relationship, Drug; Dyskinesia, Drug-In | 1978 |
Dyskinesias in monkeys: interaction of methamphetamine with prior methadone treatment.
Topics: Animals; Chlorpromazine; Clozapine; Diazepam; Dyskinesia, Drug-Induced; Haloperidol; Haplorhini; Hum | 1976 |
Susceptibility to amphetamine-elicited dyskinesias following chronic methadone treatment in monkeys.
Topics: Animals; Chlorpromazine; Clozapine; Diazepam; Drug Interactions; Dyskinesia, Drug-Induced; Haloperid | 1976 |
Narcolepsy, paranoid psychosis, and tardive dyskinesia: a pharmacological dilemma.
Topics: Chlorpromazine; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Imipramine; Male; Middle Aged; Narco | 1977 |
Neuroleptic dosage, duration, and tardive dyskinesia.
Topics: Adult; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Receptors, Dopamine; T | 1977 |
[Treatment of schizophrenia. Clinical pharmacological viewpoint].
Topics: Chlorpromazine; Drug Evaluation; Dyskinesia, Drug-Induced; Humans; Schizophrenia | 1977 |
Masking of tardive dyskinesia with four times-a-day administration of chlorpromazine.
Topics: Adult; Chlorpromazine; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Schiz | 1977 |
Diazepam in the treatment of tardive dyskinesia. Preliminary observations.
Topics: Adult; Chlorpromazine; Diazepam; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Schizo | 1976 |
"Positive" and "negative" movement disorders in schizophrenia.
Topics: Adult; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Humans; Male; Parkinson Disease, Secondary; | 1992 |
A survey of tardive dyskinesia in psychiatric inpatients in Japan.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Chlorpromazine; Dyski | 1992 |
Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.
Topics: Aged; Apomorphine; Chlorpromazine; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Dr | 1992 |
Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises.
Topics: Adult; Antipsychotic Agents; Benztropine; Chlorpromazine; Dose-Response Relationship, Drug; Dyskines | 1992 |
Tardive dyskinesia presenting as severe dysphagia.
Topics: Bipolar Disorder; Chlorpromazine; Deglutition Disorders; Dyskinesia, Drug-Induced; Female; Flupenthi | 1992 |
Tardive dyskinesia in the elderly patient.
Topics: Aged; Chlorpromazine; Chronic Disease; Clonazepam; Clozapine; Depressive Disorder; Desipramine; Diph | 1992 |
Facial dyskinesia: a 16-year follow-up study.
Topics: Affective Disorders, Psychotic; Aged; Antipsychotic Agents; Brain; Chlorpromazine; Dose-Response Rel | 1991 |
[Increased blink rate in schizophrenic patients].
Topics: Adult; Antipsychotic Agents; Blinking; Chlorpromazine; Dose-Response Relationship, Drug; Dyskinesia, | 1990 |
Phenytoin potentiation of neuroleptic-induced dyskinesias.
Topics: Animals; Chlorpromazine; Corpus Striatum; Drug Synergism; Dyskinesia, Drug-Induced; Male; Phenytoin; | 1990 |
Neurological signs and the positive-negative dimension in schizophrenia.
Topics: Adult; Chlorpromazine; Chronic Disease; Dyskinesia, Drug-Induced; Frontal Lobe; Humans; Male; Neuroc | 1990 |
Neuroleptic-induced parkinsonian side effects in the mentally handicapped.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Humans; Intellectual | 1989 |
From chlorpromazine to tardive dyskinesia (brief history of the neuroleptics).
Topics: Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; France; History, 20th Century; Human | 1989 |
Instrumental assessment of lingual motor instability in tardive dyskinesia.
Topics: Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Humans; Movement; Tongue | 1989 |
The pathophysiology of tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Chlorpromazine; Corpus Striatum; Disea | 1985 |
Interpatient variations in antipsychotic therapy.
Topics: Age Factors; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Dose-Response Relationshi | 1985 |
Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics.
Topics: Adolescent; Adult; Antipsychotic Agents; Attention; Chlorpromazine; Chronic Disease; Dyskinesia, Dru | 1985 |
[Disappearance of tardive dyskinesia in a manic attack].
Topics: Aged; Bipolar Disorder; Chlorpromazine; Dyskinesia, Drug-Induced; Humans; Male; Neurotransmitter Age | 1985 |
Effect of neuroleptics and of potential new antipsychotic agents (MJ 13859-1 and MJ 13980-1) on a monkey model of tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Cebus; Chlorpromazine; Clozapine; Dyskinesia, Drug-Induced; Female; H | 1986 |
Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
Topics: Adult; Akathisia, Drug-Induced; Ambulatory Care; Antipsychotic Agents; Basal Ganglia Diseases; Chlor | 1988 |
Psychotic patients who become worse on neuroleptics.
Topics: Adolescent; Adult; Antipsychotic Agents; Benztropine; Chlorpromazine; Dyskinesia, Drug-Induced; Fema | 1988 |
Immunogenetic markers in chlorpromazine-induced tardive dyskinesia.
Topics: Antibodies, Antinuclear; Blood Coagulation Factors; Chlorpromazine; Chronic Disease; Dyskinesia, Dru | 1986 |
Piracetam for drug-induced dyskinesia.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Humans; Piracetam; Pyrrol | 1987 |
SCH 23390 dissociated from conventional neuroleptics in apomorphine climbing and primate acute dyskinesia models.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Benz | 1985 |
Low plasma dopamine-beta-hydroxylase in demented schizophrenics.
Topics: Chlorpromazine; Chronic Disease; Dementia; Dopamine beta-Hydroxylase; Dose-Response Relationship, Dr | 1985 |
The Pisa syndrome: a report of two cases.
Topics: Adult; Chlorpromazine; Dyskinesia, Drug-Induced; Dystonia; Gait; Humans; Male; Middle Aged; Paranoid | 1985 |
Rapid induction of extrapyramidal side effects with combined use of lithium and neuroleptics.
Topics: Adult; Chlorpromazine; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Femal | 1985 |